Moderna has been awarded a potential $472M contract modification by the Biomedical Advanced Research and Development Authority to expand late-stage clinical trials of a messenger RNA-based vaccine ...
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, ...
A Moderna COVID-19 vaccine (brand name: Spikevax) photographed at Borinquen Health Care Center on May 29 in Miami. (Photo illustration by Joe Raedle/Getty Images) The Food and Drug Administration ...
Moderna has received a six-month, $1.97B contract modification from the U.S. Army to manufacture 100M more doses of the company's messenger RNA vaccine against the novel coronavirus. Army Contracting ...
Most people have put the COVID-19 pandemic behind them. Infections, vaccinations, or a combination of both have bolstered people's immunity, and while new variants continue to pop up, getting sick ...
New FDA approval language for COVID-19 vaccines is sowing confusion about which conditions put people at greater risk for severe disease and who can avoid the inconvenience and cost of off-label ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback